MedTrace Logo

The Therapeutic Effect of Dau-Di-Wu-Gong in Patient With Ankle Fracture

NCT03805347 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2021-08-09

No results posted yet for this study

Summary

Ankle fracture is one of most common bone fracture in Taiwan, although ankle fracture can be treated by surgical operation, local edema, pain and wound poor healing always is noted, according to the investigator's knowledge, no good therapeutic methods to treat mention-above symptoms until now. Helminthostachys zeylanica(L.)Hook, also called Dau-Di-U-Gon has anti-inflammation, calm down heat and detoxication, and anti-edema. People in Taiwan often uses Helminthostachys zeylanica(L.)Hook to treat bone and tendon pain, and its Ugonin component of Helminthostachys zeylanica(L.)Hook also is proved that has analgesia and ant-inflammation. Therefore, the purpose of the present study was to design a randomized, double-blind, controlled study to evaluate functional recovery effect of Helminthostachys zeylanica(L.)Hook after surgical operation in patients with ankle fracture.

Conditions

  • Ankle Fractures

Interventions

DRUG

Helminthostachys zeylanica(L.)Hook

Extract of Helminthostachys zeylanica(L.)Hook, 1gm/time, 3 times daily

DRUG

Starch

Starch in capsule, 1gm/time, 3 times daily

Sponsors & Collaborators

  • Changhua Christian Hospital

    lead OTHER

Principal Investigators

  • Ching Liang Hsieh, MD, PhD · Graduate Institute of Integrated Medicine,China Medical University,Taiwan.

  • Lun Chien Lo, MD, PhD · School of Chinese Medicine,China Medical University,Taiwan.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-12
Primary Completion
2021-01-11
Completion
2021-01-11

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03805347 on ClinicalTrials.gov